4//SEC Filing
BREITMEYER JAMES B 4
Accession 0001209191-24-000970
CIK 0001260990other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:00 PM ET
Size
7.9 KB
Accession
0001209191-24-000970
Insider Transaction Report
Form 4
BREITMEYER JAMES B
DirectorPresident, CEO
Transactions
- Tax Payment
Common Stock
2024-01-03$0.50/sh−50,955$25,279→ 443,034 total - Tax Payment
Common Stock
2024-01-03$0.50/sh−4,485$2,225→ 15,426 total(indirect: By Spouse)
Holdings
- 196,544(indirect: By Trust)
Common Stock
- 733(indirect: By Children)
Common Stock
Footnotes (1)
- [F1]Shares withheld by the Issuer to satisfy statutory tax withholding requirements on vesting of restricted stock units.
Documents
Issuer
Oncternal Therapeutics, Inc.
CIK 0001260990
Entity typeother
Related Parties
1- filerCIK 0001244823
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:00 PM ET
- Size
- 7.9 KB